Healthcare Sales & Marketing Network News: Macular Degeneration

Searching News Database: Macular Degeneration

HSMN NewsFeed - 24 Jul 2024
Beacon Therapeutics Appoints Lance Baldo, MD as Chief Executive Officer and Thomas Biancardi as Chief Financial Officer
Biopharmaceuticals Ophthalmology Personnel

HSMN NewsFeed - 3 Jul 2024
Beacon Therapeutics Raises $170 Million in Series B Funding to Advance Development of Ophthalmic Gene Therapies
Regenerative Medicine Ophthalmology Venture Capital

HSMN NewsFeed - 21 May 2024
Biocon Biologics Obtains U.S. FDA Approval for Biosimilar Aflibercept for Yesafili(TM). Enters U.S. Ophthalmology Market
Biopharmaceuticals Generics Ophthalmology FDA

HSMN NewsFeed - 14 May 2024
Nanoscope Therapeutics Appoints Khandan Baradaran as Senior Vice President of Regulatory and Quality
Regenerative Medicine Ophthalmology Personnel

HSMN NewsFeed - 3 Jul 2023
Skyline Therapeutics Receives FDA Clearance of IND for SKG0106, a Novel Intravitreally Delivered AAV Gene Therapy Candidate for Neovascular Age-related Macular Degeneration
Regenerative Medicine Ophthalmology FDA

HSMN NewsFeed - 5 Jun 2023
Visgenx Appoints William Pedranti as Chief Executive Officer
Regenerative Medicine Ophthalmology Personnel

HSMN NewsFeed - 5 Jan 2023
Perceive Biotherapeutics Attracts $78M Series B Financing to Advance Diversified Pipeline
Biopharmaceuticals Ophthalmology Venture Capital

HSMN NewsFeed - 21 Oct 2022
Regeneron Receives Six Months of U.S. Pediatric Exclusivity for EYLEA(R) (aflibercept) Injection
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 8 Aug 2022
Kodiak Sciences Reports Positive Topline Results from BEACON Phase 3 Study of Tarcocimab Tedromer (KSI-301) in Patients with Retinal Vein Occlusion
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 18 Jul 2022
Carl Zeiss Meditec and Precise Bio Announce Partnership in the Development and Commercialization of Tissue-Based Implants for Ophthalmology
Regenerative Medicine Ophthalmology

HSMN NewsFeed - 29 Jun 2022
EYLEA(R) (aflibercept) Injection sBLA for Every 16-week Dosing Regimen in Patients with Diabetic Retinopathy Accepted for FDA Review
Biopharmaceuticals FDA

HSMN NewsFeed - 18 Apr 2022
Nanoscope Therapeutics Appoints Pharma Industry Veteran Aaron Osborne, MBBS, as Chief Medical Officer and Chief Development Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Mar 2022
LumiThera, Inc. Announces Completion of Diopsys, Inc. Acquisition
Devices Ophthalmology Mergers & Acquisitions

HSMN NewsFeed - 4 Feb 2022
Regenerative Patch Technologies Presents Clinical Data Demonstrating Long-Term Survival and Function of an Allogenic Bioengineered Cellular Implant in Patients with Advanced Dry Aged-Related Macular Degeneration
Regenerative Medicine Ophthalmology

HSMN NewsFeed - 25 Jan 2022
Nanoscope Therapeutics Announces FDA Clearance of IND for MCO-010 Gene Therapy in Stargardt Macular Degeneration Patients
Regenerative Medicine Ophthalmology FDA

HSMN NewsFeed - 11 Nov 2021
LumiThera, Inc. Announces Creation of a Light-based Theranostic Approach to Treat Ocular Disease with Acquisition of Diopsys, Inc.
Devices Ophthalmology Mergers & Acquisitions

HSMN NewsFeed - 13 Sep 2021
AbbVie and REGENXBIO Announce Eye Care Collaboration
Biopharmaceuticals Regenerative Medicine Ophthalmology

HSMN NewsFeed - 7 May 2021
LumiThera Presents Valeda Treatment Benefits for Photobiomodulation in Early Patients with Diabetic Retinopathy and Macular Edema
Devices Ophthalmology

HSMN NewsFeed - 7 Apr 2021
LumiThera Announces Top Line Data in the European Multi-Center, LIGHTSITE II Clinical Study to Treat Dry Age-Related Macular Degeneration
Devices Ophthalmology

HSMN NewsFeed - 21 Sep 2020
Bausch Health To Acquire Option To Purchase All Ophthalmology Assets Of Allegro Ophthalmics
Biopharmaceuticals Ophthalmology Acquisitions

HSMN NewsFeed - 17 Jul 2020
Interim Six-Month Data of RPGR Gene Therapy Shows Significant Vision Improvement in Patients Living with X-Linked Retinitis Pigmentosa
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 8 Jul 2020
LumiThera Closes Series C Round of Financing
Devices Ophthalmology Venture Capital

HSMN NewsFeed - 3 Mar 2020
FDA Grants Rare Pediatric Disease Designation to Stealth BioTherapeutics for Elamipretide for the Treatment of Barth Syndrome
Biopharmaceuticals FDA

HSMN NewsFeed - 13 Jan 2020
LumiThera Closes 2nd Tranche of Series C Financing
Devices Ophthalmology Venture Capital

HSMN NewsFeed - 13 Jan 2020
Exonate Announces Collaboration With Janssen to Develop a New Eye Drop for the Treatment of Retinal Vascular Diseases Including Wet Age-related Macular Degeneration (AMD) and Diabetic Macular Edema
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 2 Dec 2019
Kodiak Sciences Announces Sale of Future Royalties on KSI-301 for $225 Million to Baker Bros. Advisors
Biopharmaceuticals Ophthalmology Venture Capital

HSMN NewsFeed - 4 Sep 2019
REGENXBIO Announces Exclusive Worldwide Option and License Agreement with Clearside Biomedical for Evaluation of In-Office Delivery Platform for RGX-314
Biopharmaceuticals Drug Delivery Licensing

HSMN NewsFeed - 13 Aug 2019
FDA Approves EYLEA(R) (aflibercept) Injection Prefilled Syringe
Biopharmaceuticals Drug Delivery Ophthalmology FDA

HSMN NewsFeed - 11 Dec 2018
LumiThera Announces a Distribution Agreement for the Valeda Light Delivery System with Miloftalmica in Italy
Devices Ophthalmology Distribution

HSMN NewsFeed - 25 Oct 2018
EYLEA(R) (aflibercept) Injection Improves Diabetic Retinopathy and Reduces Vision-Threatening Complications in Phase 3 Trial
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 3 Oct 2018
Rewind Therapeutics Appoints Leading Neuroscience Drug Developer Ian J. Reynolds as Chief Executive Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 24 Sep 2018
Oculis Appoints World-renowned Ophthalmology Specialist
Biopharmaceuticals Ophthalmology Personnel

HSMN NewsFeed - 13 Sep 2018
FDA to Review EYLEA (aflibercept) Injection for the Treatment of Diabetic Retinopathy
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 17 Aug 2018
FDA Approves EYLEA(R) (aflibercept) Injection sBLA in Wet Age-related Macular Degeneration
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 13 Aug 2018
Regeneron Provides Regulatory Update on EYLEA(R) (aflibercept) Injection sBLA in Wet Age-Related Macular Degeneration
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 9 Jul 2018
Oculocare's Alleye(R) Receives FDA 510(k) Clearance for Monitoring Eyesight in AMD
Devices Diagnostics Ophthalmology FDA

HSMN NewsFeed - 24 Apr 2018
Lin BioScience Announces FDA Orphan Drug Designation for LBS-007 for the Treatment of Acute Lymphoblastic Leukemia
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 12 Apr 2018
FDA Permits Marketing of IDx-DR for Automated Detection of Diabetic Retinopathy in Primary Care
Devices Ophthalmology FDA Product Launch

HSMN NewsFeed - 19 Mar 2018
EYLEA(R) (aflibercept) Injection Demonstrates Positive Topline Results in Phase 3 Non-Proliferative Diabetic Retinopathy Trial
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 14 Feb 2018
Phase II Data Support Potential for Novel Anti-VEGF/Anti-Angiopoietin-2 Bispecific Antibody, RG7716, for People With Diabetic Macular Edema
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 11 Dec 2017
Regeneron Announces FDA Acceptance of sBLA Filing for 12-Week Dosing of EYLEA(R) (aflibercept) Injection for Patients with Wet AMD
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 27 Nov 2017
Stealth BioTherapeutics Granted Fast Track Designation for the Treatment of Barth Syndrome
Biopharmaceuticals FDA

HSMN NewsFeed - 27 Nov 2017
Regeneron Provides Update on EYLEA(R) (aflibercept) Injection and Nesvacumab (Ang2 Antibody) Combination Program
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 31 Oct 2017
LumiThera Closes Series B Round of Financing
Devices Ophthalmology Venture Capital Personnel

HSMN NewsFeed - 9 Aug 2017
Ocugen Receives FDA Orphan Drug Designation for OCU300 (brimonidine tartrate) for the Treatment of Ocular Graft Versus Host Disease
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 19 Jun 2017
Ocugen Makes Strategic Appointments to Management Team
Biopharmaceuticals Ophthalmology Personnel

HSMN NewsFeed - 28 Mar 2017
ONL Therapeutics Strengthens Leadership with Addition to Board of Directors and Expansion of Operations Team
Biopharmaceuticals Ophthalmology Personnel

HSMN NewsFeed - 11 Jan 2017
FDA Grants VisionCare Inc. Approval to Initiate Clinical Study of the Telescope Implant in Post-Cataract Patients
Devices Ophthalmology FDA

HSMN NewsFeed - 3 Jan 2017
Graybug Vision Appoints Thomas S. Templeman, PhD, as Chief Operating Officer
Biopharmaceuticals Ophthalmology Personnel

HSMN NewsFeed - 12 Dec 2016
Ophthotech Announces Results from Pivotal Phase 3 Trials of Fovista(R) in Wet Age-Related Macular Degeneration
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 1 Dec 2016
Exonate Closes Successful Funding Round - To Develop Eye Drops Treatment for Wet Age-related Macular Degeneration (Wet AMD)
Biopharmaceuticals Ophthalmology Venture Capital

HSMN NewsFeed - 18 Nov 2016
AGTC Appoints Michael Goldstein, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Oct 2016
Ocular Therapeutix(TM) and Regeneron Enter Into Strategic Collaboration to Develop Sustained Release Formulation of Aflibercept for the Treatment of Wet AMD and Other Serious Retinal Diseases
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 11 Oct 2016
FDA Grants Priority Review to Genentech’s Lucentis(R) (Ranibizumab Injection) Supplemental Biologics License Application for Myopic Choroidal Neovascularization
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 8 Aug 2016
Apellis Pharmaceuticals Announces Appointment of Dr. Robert Kim as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Aug 2016
pSivida Corp and Hospital for Special Surgery Innovation Center Announce Opening of IND for Sustained-Release Implant for Severe Knee Osteoarthritis
Devices Drug Delivery Orthopaedic

HSMN NewsFeed - 28 Jun 2016
iSTAR Medical Strengthens Board With Two Senior Appointments
Devices Ophthalmology Personnel

HSMN NewsFeed - 16 Jun 2016
Valeant Pharmaceuticals Announces Launch Of New PreserVision(R) AREDS 2 Formula + Multivitamin
Biopharmaceuticals Ophthalmology Product Launch

HSMN NewsFeed - 31 May 2016
Pixium Vision Receives Clinical Trial Approval from UK Regulatory Authority for 150 Electrode IRIS(R)II Bionic Vision System
Devices Ophthalmology Regulatory

HSMN NewsFeed - 5 May 2016
Investigational Gene-Based Therapy for Alpha-1 Antitrypsin (AAT) Deficiency Demonstrates Durable Response at Five Years
Biopharmaceuticals

HSMN NewsFeed - 4 May 2016
Notal Vision Announces Appointment of Quinton Oswald as Chief Executive Officer
Devices Monitoring Ophthalmology Personnel

HSMN NewsFeed - 2 May 2016
Graybug Vision Announces $44.5 Million Series B Financing
Biopharmaceuticals Ophthalmology Venture Capital

HSMN NewsFeed - 23 Mar 2016
Envisia Therapeutics Secures $16.5 Million In Additional Series A Financing
Biopharmaceuticals Ophthalmology Venture Capital

HSMN NewsFeed - 12 Feb 2016
Apellis Completes $47 Million Series D Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 18 Jan 2016
iCo Strategic Reorganization
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Jan 2016
Iconic Therapeutics Closes Series C Financing With New and Existing Investors
Biopharmaceuticals Oncology Ophthalmology Venture Capital

HSMN NewsFeed - 5 Jan 2016
Glenn P. Sblendorio to Join Ophthotech as Executive Vice President, Chief Operating Officer and Chief Financial Officer
Biopharmaceuticals Ophthalmology Personnel

HSMN NewsFeed - 3 Dec 2015
Clearside Biomedical, Inc. Completes $20 Million Series C Financing
Biopharmaceuticals Ophthalmology Venture Capital

HSMN NewsFeed - 12 Nov 2015
RetroSense Therapeutics Raises $6 million in an Over-Subscribed Series B Financing to Advance Clinical Development of Lead Product RST-001 for Retinitis Pigmentosa
Biopharmaceuticals Ophthalmology Venture Capital

HSMN NewsFeed - 30 Oct 2015
Regeneron Announces EU Approval of EYLEA(R) (aflibercept) Injection for the Treatment of Visual Impairment Secondary to Myopic Choroidal Neovascularization
Biopharmaceuticals Ophthalmology Regulatory

HSMN NewsFeed - 21 Oct 2015
Allegro Ophthalmics Names Scott Cooper as Chief Financial Officer and Vice President of Business Development and Mohamed Genead, MD, as Executive Medical Director
Biopharmaceuticals Ophthalmology Personnel

HSMN NewsFeed - 15 Sep 2015
Makindus Bolsters Management Team with Appointment of Michael Celano as Chief Financial Officer
Biopharmaceuticals Ophthalmology Personnel

HSMN NewsFeed - 5 Aug 2015
Ohr Pharmaceutical Promotes Jason S. Slakter, MD to Chief Executive Officer
Biopharmaceuticals Ophthalmology Personnel

HSMN NewsFeed - 22 Jul 2015
Second Sight Announces First Age-Related Macular Degeneration Patient Receives the Argus II Retinal Prosthesis System as Part of Groundbreaking Study
Devices Ophthalmology

HSMN NewsFeed - 21 Jul 2015
Ophthotech Announces New Senior Leadership Appointments
Biopharmaceuticals Ophthalmology Personnel

HSMN NewsFeed - 15 Jul 2015
OncoCyte Announces Appointment of Andy Arno to Board of Directors
Diagnostics Oncology Personnel

HSMN NewsFeed - 26 Jun 2015
EYLEA(R) (aflibercept) Injection Receives Approval in Japan for the Treatment of Retinal Vein Occlusion
Biopharmaceuticals Ophthalmology Regulatory

HSMN NewsFeed - 19 Jun 2015
OphthaliX Signs Definitive Agreement to Acquire Improved Vision Systems Ltd.
Biopharmaceuticals Ophthalmology Mergers & Acquisitions

HSMN NewsFeed - 16 Jun 2015
William Annett Named Chief Executive Officer of OncoCyte Corporation
Diagnostics Oncology Personnel

HSMN NewsFeed - 14 May 2015
OncoCyte Corporation Completes Equity Financing Round
Diagnostics Oncology Venture Capital

HSMN NewsFeed - 22 Apr 2015
SciFluor Life Sciences Raises $30 Million and Names William Koster, PhD, Former CEO of Neurogen Corp., as Chairman
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 31 Mar 2015
Tyrogenex, Xcovery Appoint Michael Webb as President and Chief Executive Officer
Biopharmaceuticals Ophthalmology Oncology Personnel

HSMN NewsFeed - 24 Mar 2015
StemCells, Inc. Appoints Ian Massey as President and Chief Operating Officer
Regenerative Medicine Neurology Personnel

HSMN NewsFeed - 3 Mar 2015
Oraya Therapeutics' AMD Radiotherapy Device Receives New Indication of Use for Choroidal Metastases
Devices Oncology Regulatory

HSMN NewsFeed - 26 Feb 2015
EYLEA(R) (aflibercept) Injection Receives EU Approval for the Treatment of Visual Impairment Due to Macular Edema Secondary to Retinal Vein Occlusion
Biopharmaceuticals Ophthalmology Regulatory

HSMN NewsFeed - 29 Dec 2014
BioTime Appoints Adi Mohanty Chief Operating Officer
Regenerative Medicine Personnel

HSMN NewsFeed - 24 Nov 2014
Agilis Biotherapeutics Names Former Shire Executive Dr. Gregory Robinson as Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Nov 2014
Jade Therapeutics Names Ophthalmology Pioneer Randall Olson, M.D., to its Board of Directors
Biopharmaceuticals Ophthalmology Drug Delivery Personnel

HSMN NewsFeed - 4 Nov 2014
BioTime Receives Authorization to Begin Pivotal Human Clinical Trial of Renevia(TM) in Europe
Regenerative Medicine HIV/AIDS

HSMN NewsFeed - 17 Oct 2014
EYLEA(R) (aflibercept) Injection Demonstrates Significantly Greater Gains in Visual Acuity than Both Bevacizumab and Ranibizumab in NIH-Sponsored Diabetic Macular Edema Study
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 13 Oct 2014
FDA Approves VisionCare's Telescope Implant for Macular Degeneration in Patients 65 Years and Older
Devices Ophthalmology FDA

HSMN NewsFeed - 3 Oct 2014
Ophthotech Corporation Names Todd N. Smith as Chief Commercial Officer
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 22 Sep 2014
Regeneron Announces EYLEA(R) (aflibercept) Injection Approved for the Treatment of Patients with Myopic Choroidal Neovascularization (CNV) in Japan
Biopharmaceuticals Ophthalmology Regulatory

HSMN NewsFeed - 11 Aug 2014
EYLEA(R) (aflibercept) Injection Receives EU Approval for the Treatment of Diabetic Macular Edema (DME)
Biopharmaceuticals Ophthalmology Regulatory

HSMN NewsFeed - 4 Aug 2014
RestorGenex Appoints Mark Weinberg, MD, MBA Senior Vice President of Clinical Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Jul 2014
RestorGenex Announces Management Changes
Biopharmaceuticals Dermatology Ophthalmology Personnel

HSMN NewsFeed - 30 Jun 2014
Allergan Announces R&D Pipeline Update and U.S. FDA Approval; Company to Host Conference Call Today, Monday, June 30th at 10:30 AM ET
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 27 Jun 2014
EYLEA(R) (aflibercept) Injection Recommended for Approval for the Treatment of Visual Impairment due to Diabetic Macular Edema in the European Union
Biopharmaceuticals Ophthalmology Regulatory

HSMN NewsFeed - 19 Jun 2014
Tyrogenex Raises $15M in Series D Financing from Brace Pharma, US Investment Arm of EMS S/A
Biopharmaceuticals Ophthalmology Venture Capital

HSMN NewsFeed - 4 Jun 2014
CenterVue Announces FDA Clearance of Next Generation Macular Integrity Assessment (MAIA)
Devices Ophthalmology FDA

HSMN NewsFeed - 23 Apr 2014
Kala Pharmaceuticals Announces $22.5 Million Series B Financing
Biopharmaceuticals Ophthalmology Venture Capital

HSMN NewsFeed - 10 Feb 2014
Two-Year Results From Phase 3 VISTA Trial of EYLEA(R) (aflibercept) Injection for the Treatment of Diabetic Macular Edema Show Sustained Improvement in Vision
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 22 Jan 2014
Advanced Cell Technology Announces Change in Management
Regenerative Medicine Ophthalmology Personnel

HSMN NewsFeed - 17 Jan 2014
Sequenom Laboratories grants Nicox exclusive promotion and marketing rights for its RetnaGene(TM) AMD test in North America
Diagnostics Ophthalmology Licensing

HSMN NewsFeed - 6 Jan 2014
Kala Pharmaceuticals Appoints Howard B. Rosen as Chairman of the Board of Directors
Biopharmaceuticals Ophthalmology Personnel

HSMN NewsFeed - 18 Dec 2013
Regeneron Announces FDA Acceptance of EYLEA(R) (aflibercept) Injection Supplemental Biologics License Application for Review for Diabetic Macular Edema Indication
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 12 Dec 2013
Advanced Cell Technology Appoints Eddy Anglade M.D. Executive Vice President of Clinical Development
Regenerative Medicine Personnel

HSMN NewsFeed - 25 Nov 2013
Pixium Vision raises €15 million led by Sofinnova Partners
Devices Ophthalmology Venture Capital

HSMN NewsFeed - 22 Nov 2013
EYLEA(R) (aflibercept) Injection Approved For The Treatment of Macular Edema Following Central Retinal Vein Occlusion In Japan
Biopharmaceuticals Ophthalmology Regulatory

HSMN NewsFeed - 12 Nov 2013
Bayer receives approval for Eylea(R) as new drug to treat wet Age-Related Macular Degeneration Patients in Canada
Biopharmaceuticals Ophthalmology Regulatory

HSMN NewsFeed - 6 Aug 2013
James Mazzo Appointed Executive Chairman of Neurotech Pharmaceuticals
Biopharmaceuticals Drug Delivery Ophthalmology Personnel

HSMN NewsFeed - 26 Jul 2013
EYLEA(R) (aflibercept) Injection Recommended for Approval for the Treatment of Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion in Europe
Biopharmaceuticals Ophthalmology Regulatory

HSMN NewsFeed - 29 May 2013
Ophthotech Raises $175 Million to Finance the Pivotal Phase 3 Program for Fovista(TM) Anti-PDGF Combination Therapy in Wet AMD
Biopharmaceuticals Ophthalmology Personnel

HSMN NewsFeed - 22 May 2013
Ohr Pharmaceutical Appoints June S. Almenoff to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Apr 2013
New Therapy for Wet AMD Introduced in Switzerland by Oraya(R) Therapeutics and EyeRAD
Devices Ophthalmology

HSMN NewsFeed - 11 Mar 2013
MacuLogix Raises $3.6 Million in Series A Round
Diagnostics Ophthalmology Venture Capital

HSMN NewsFeed - 4 Mar 2013
Clearside Biomedical, Inc. Names Stephen H. Lang Vice President, Commercial Operations
Biopharmaceuticals Ophthalmology Personnel

HSMN NewsFeed - 28 Feb 2013
Kala Pharmaceuticals Secures $11.5 Million in Series A Financing
Biopharmaceuticals Drug Delivery Venture Capital

HSMN NewsFeed - 19 Feb 2013
Regeneron and Bayer Initiate Phase 3 Trial of EYLEA(R) (aflibercept) Injection for the Treatment of Diabetic Macular Edema in Asia and Russia
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 6 Dec 2012
EYLEA(R) (aflibercept) Submitted for EU Marketing Authorization for the Treatment of Macular Edema Following Central Retinal Vein Occlusion
Biopharmaceuticals Ophthalmology Regulatory

HSMN NewsFeed - 27 Nov 2012
EYLEA(R) (aflibercept) Injection Approved for the Treatment of Wet Age-Related Macular Degeneration in Europe
Biopharmaceuticals Ophthalmology Regulatory

HSMN NewsFeed - 19 Nov 2012
AGTC Secures $37.5M Series B Funding
Biopharmaceuticals Ophthalmology Venture Capital

HSMN NewsFeed - 15 Oct 2012
Promedior Appoints Elizabeth Trehu, M.D., as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Oct 2012
Promedior Expands Series D Round of Financing to Total $24.5 Million to Advance Pipeline of Pentraxin-2 Therapeutics for Fibrotic Diseases
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 30 Aug 2012
Aerpio Therapeutics Completes $27 Million Series A Financing
Biopharmaceuticals Ophthalmology Venture Capital

HSMN NewsFeed - 26 Jul 2012
FDA Advisory Committee Unanimously Recommends Approval of Lucentis for Treatment of Diabetic Macular Edema (DME)
Biopharmaceuticals Ophthalmology Endocrinology FDA

HSMN NewsFeed - 14 May 2012
FDA Grants Fast Track Designation to Ohr Pharmaceutical's Squalamine Eye Drops for the Treatment of Wet-AMD
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 3 May 2012
Oraya Therapeutics Achieves Successful INTREPID Study Outcomes with a Non-Invasive Radiation Therapy for Wet AMD
Devices Ophthalmology

HSMN NewsFeed - 2 May 2012
ACT Announces Massachusetts Eye and Ear as Additional Site for Clinical Trial for Dry Age-Related Macular Degeneration Using Human Embryonic Stem Cell-Derived RPE Cells
Regenerative Medicine Ophthalmology

HSMN NewsFeed - 19 Apr 2012
RetroSense Welcomes Dr. Peter Francis as Clinical Director
Regenerative Medicine Ophthalmology Personnel

HSMN NewsFeed - 16 Apr 2012
QLT Announces the Appointment of Christopher Muller as Chief Commercial Officer
Biopharmaceuticals Ophthalmology Personnel

HSMN NewsFeed - 11 Apr 2012
MacuCLEAR, Inc. To Begin Phase III Study of its Lead Compound for Early-Stage Age-Related Macular Degeneration (AMD)
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 5 Apr 2012
Sanofi and Regeneron Announce Regulatory and Clinical Update for ZALTRAP(R) (aflibercept)
Biopharmaceuticals

HSMN NewsFeed - 19 Mar 2012
QLT Receives Orphan Drug Designation for Visudyne for Treatment of Central Serous Chorioretinopathy
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 8 Mar 2012
Regeneron and Bayer Announce Approval of EYLEA(R) (aflibercept) Injection for the Treatment of Wet Age-Related Macular Degeneration in Australia
Biopharmaceuticals Ophthalmology Regulatory

HSMN NewsFeed - 13 Feb 2012
Valeant Pharmaceuticals to Acquire Eyetech
Biopharmaceuticals Ophthalmology Mergers & Acquisitions

HSMN NewsFeed - 3 Jan 2012
New Study Links Daily Aspirin Use to Increased Risk of Age-Related Macular Degeneration
Biopharmaceuticals Cardiology Ophthalmology

HSMN NewsFeed - 7 Dec 2011
Icon Appoints Murahashi Vice President, Clinical Development
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 11 Oct 2011
iScience Interventional Receives Investment Which Accelerates Microcatheter Commercialization Activities
Devices Ophthalmology Interventional

HSMN NewsFeed - 8 Aug 2011
Acucela Appoints Michelle Carpenter, J.D., RAC, as Senior Vice President, Regulatory Affairs & Development Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Jun 2011
XOMA Appoints Paul Rubin, M.D. as Vice President and Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Jun 2011
ZALTRAP (aflibercept) Significantly Improved Survival in Previously Treated Metastatic Colorectal Cancer Patients
Biopharmaceuticals Oncology

HSMN NewsFeed - 18 Apr 2011
FDA Grants Priority Review for VEGF Trap-Eye for the Treatment of Wet Age-Related Macular Degeneration
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 8 Apr 2011
Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 25 Mar 2011
Second Lucentis Phase III Study Meets Primary Endpoint for Improved Vision in Patients with Diabetic Macular Edema (DME)
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 24 Mar 2011
Bausch & Lomb Appoints David Mordaunt, Ph.D. as Vice President, Development and Research, Surgical
Devices Ophthalmology Personnel

HSMN NewsFeed - 10 Mar 2011
Sanofi-aventis and Regeneron Report Top-line Results from Phase III Study with aflibercept (VEGF Trap) in Second-Line Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 1 Mar 2011
Paloma Pharmaceuticals Update on Ocular Clinical and Oncology Programs
Biopharmaceuticals Ophthalmology Oncology

HSMN NewsFeed - 11 Feb 2011
Lucentis Phase III Study Meets Primary Endpoint for Improving Vision in Patients With Diabetic Macular Edema (DME)
Biopharmaceuticals Endocrinology Ophthalmology

HSMN NewsFeed - 10 Jan 2011
VisionCare Ophthalmic Technologies Closes $31 Million Series E Financing
Devices Ophthalmology Venture Capital

HSMN NewsFeed - 20 Dec 2010
Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and in Phase 2 Study in Diabetic Macular Edema (DME)
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 7 Dec 2010
StemCells, Inc. Receives Authorization to Conduct World's First Neural Stem Cell Trial in Spinal Cord Injury
Regenerative Medicine Neurology

HSMN NewsFeed - 30 Nov 2010
VisionCare Appoints Richard Powers Executive Vice President
Devices Ophthalmology Personnel

HSMN NewsFeed - 15 Nov 2010
Christine A. Poon Elected to Regeneron Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Sep 2010
Microplasmin Meets Primary Endpoint in Second Phase III Trial in VMA, Confirms Positive Findings of First Trial
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 26 Aug 2010
XOMA Appoints Jack L. Wyszomierski to Its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Aug 2010
Taligen Closes $10 Million Series B Financing Tranche
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 13 Aug 2010
Inspire Names Dr. Charles Johnson as Executive Vice President of Research and Development and Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Jul 2010
NovaVision's FDA-Cleared Visual Restoration Therapy (VRT) System and Company Assets Now Available
Devices

HSMN NewsFeed - 6 Jul 2010
VisionCare Announces FDA Approval for First-Ever Implantable Telescope for End-Stage Macular Degeneration
Devices Ophthalmology FDA

HSMN NewsFeed - 22 Jun 2010
QLT Announces Final Results From Its RADICAL Study Evaluating Verteporfin PDT (Visudyne(R)) Combination Therapy in Exudative AMD
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 10 Jun 2010
Quark Pharmaceuticals Closes $10 Million Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 30 Apr 2010
IRIDEX Announces First Commercial Shipment of New IQ 532(TM) Laser Systems
Devices Ophthalmology

HSMN NewsFeed - 12 Apr 2010
QLT Names Dipak Panigrahi, M.D., as Chief Medical Officer
Biopharmaceuticals Ophthalmology Personnel

HSMN NewsFeed - 7 Apr 2010
Oraya Therapeutics Granted European CE Mark for the IRay(TM) Stereotactic Radiotherapy System
Devices Ophthalmology Regulatory

HSMN NewsFeed - 6 Apr 2010
IMI Intelligent Medical Implants Names Robert J. Rosenthal Chief Executive Officer
Devices Ophthalmology Personnel

HSMN NewsFeed - 16 Mar 2010
Promedior Closes $12 Million Series C Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 16 Feb 2010
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of Delayed Graft Function in Kidney Transplant Patients
Biopharmaceuticals FDA

HSMN NewsFeed - 11 Feb 2010
OXiGENE Announces Restructuring to Focus Resources on Key Programs and Provides Business Update
Biopharmaceuticals

HSMN NewsFeed - 9 Feb 2010
Sequenom Licenses Worldwide Rights to Develop Age-Related Macular Degeneration Diagnostic Test
Diagnostics Ophthalmology Licensing

HSMN NewsFeed - 29 Jan 2010
Study Published in the American Journal of Ophthalmology Examines Investigational Use of Macugen in Patients With Branch Retinal Vein Occlusion (BRVO)
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 5 Jan 2010
Oraya Therapeutics Initiates First Ever Sham-Controlled Study of Radiation Therapy for Wet AMD
Devices Ophthalmology

HSMN NewsFeed - 16 Dec 2009
Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company
Biopharmaceuticals Mergers & Acquisitions Personnel

HSMN NewsFeed - 15 Dec 2009
Ophthotech Raises $30 Million in Series B Financing
Biopharmaceuticals Ophthalmology Venture Capital

HSMN NewsFeed - 18 Nov 2009
StemCells, Inc. Provides Update on NCL Program Meeting with FDA
Regenerative Medicine Neurology FDA

HSMN NewsFeed - 17 Nov 2009
XOMA Appoints Jim Neal Vice President of Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Oct 2009
Auxano Diagnostics, LLC Announces a New Point-of-Care Indicator System for Dry Eye Syndrome
Diagnostics Ophthalmology Wound Care

HSMN NewsFeed - 21 Oct 2009
MacuSight(R) Receives Fast Track Designation From FDA for Perceiva(TM) in Treatment of Diabetic Macular Edema
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 19 Oct 2009
QLT restructures Visudyne(R) agreement
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 14 Oct 2009
XOMA Appoints Susan Kramer, Dr. P.H. Vice President of Project and Alliance Management
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Oct 2009
SurModics Enters Ophthalmic License and Development Agreement with Roche and Genentech
Biopharmaceuticals Ophthalmology Drug Delivery Licensing

HSMN NewsFeed - 4 Aug 2009
Oraya Therapeutics Names Jim Taylor as President and Chief Executive Officer
Devices Ophthalmology Personnel

HSMN NewsFeed - 30 Jul 2009
Second Phase III Study Showed Lucentis Improved Vision in Patients With Retinal Vein Occlusion
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 20 Jul 2009
Oraya Therapeutics Raises $42 Million in Series C Financing
Devices Ophthalmology Venture Capital

HSMN NewsFeed - 14 Jul 2009
Novadaq Receives FDA Clearance for SPY Endoscopic Imaging System
Devices FDA

HSMN NewsFeed - 30 Jun 2009
Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products
Biopharmaceuticals

HSMN NewsFeed - 15 Jun 2009
QLT announces 12-month results from Novartis sponsored MONT BLANC study evaluating standard-fluence Visudyne(R) combination therapy
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 26 May 2009
Ophthonix Completes Series AA Financing at $25.9 Million
Devices Ophthalmology Venture Capital

HSMN NewsFeed - 5 May 2009
Breakthrough Medical Device Gives Hope for Blindness-Related Diseases
Devices Ophthalmology

HSMN NewsFeed - 30 Apr 2009
Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 21 Apr 2009
iScience Interventional, Inc. Closes $20.5 million Series F Financing
Devices Ophthalmology Venture Capital

HSMN NewsFeed - 15 Apr 2009
Resolvyx Appoints Industry Leader Philip Vickers as Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Apr 2009
TransMolecular Appoints Robert Radie President and Chief Executive Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 10 Mar 2009
Revolutionary Genetic Test Now Available for Age-Related Macular Degeneration
Diagnostics Ophthalmology

HSMN NewsFeed - 16 Feb 2009
Sirion Therapeutics Partners With Advanced Vision Research (TheraTears(R)) to Promote Products for Retinal and Meibomian Gland Health
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 15 Jan 2009
XOMA Announces Workforce Reduction
Biopharmaceuticals

HSMN NewsFeed - 14 Jan 2009
Novadaq Completes Staff Reductions & Announces Management Changes
Devices Surgery Personnel

HSMN NewsFeed - 14 Jan 2009
Novadaq Signs License, Development and Supply Agreements With Intuitive
Devices Surgery

HSMN NewsFeed - 22 Dec 2008
TransMolecular Receives Orphan Drug Designation for 131I-TM601 for the Treatment of Melanoma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 3 Dec 2008
Catalyst Biosciences Raises $40 Million in Series C Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 6 Nov 2008
MacuSight Appoints Gerald Wroblewski Vice President of Operations
Biopharmaceuticals Ophthalmology Personnel

HSMN NewsFeed - 23 Oct 2008
OXiGENE, Inc. Names John A. Kollins as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Oct 2008
Tracon Pharmaceuticals Appoints Bryan Leigh, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Sep 2008
ISTA Pharmaceuticals Receives $65 Million Funding Commitment
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 17 Sep 2008
Merck & Co., Inc. Discontinues License and Research Collaboration Agreement with SurModics
Biopharmaceuticals Drug Delivery Licensing

HSMN NewsFeed - 3 Sep 2008
Neurotech Granted Fast Track Designations from the FDA for NT-501 in Two Indications - Retinitis Pigmentosa and Dry Age-Related Macular Degeneration
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 19 Aug 2008
Regeneron and Bayer HealthCare Announce VEGF Trap-Eye Achieved Durable Improvement in Vision over 52 Weeks in a Phase 2 Study in Patients with Age-Related Macular Degeneration
Biopharmaceuticals Opthalmology

HSMN NewsFeed - 22 Jul 2008
PhiloGene, Inc. Announces that VEGFb(TM) has been Granted Orphan Drug Designation by the FDA for the Treatment of Advanced Melanoma
Biopharmaceuticals FDA Oncology

HSMN NewsFeed - 11 Jul 2008
Alcon Terminates the Development of Anecortave Acetate in Age-Related Macular Degeneration
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 9 Jul 2008
Pipex Pharmaceuticals Announces Results of Eighty Patient, Six Month, Prospective, Randomized, Double-Blind Clinical Trial of Oral Zinthionein for Dry Age-Related Macular Degeneration (AMD)
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 8 Jul 2008
Pipex Pharmaceuticals Appoints Co-Founder and Vice Chairman Nicholas Stergis as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Jul 2008
Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 23 Jun 2008
EyeCyte, Inc. Secures Series A Funding from Pfizer
Biopharmaceuticals Regenerative Medicine Venture Capital

HSMN NewsFeed - 12 May 2008
Pipex Pharmaceuticals Receives FDA Orphan Drug Designation for Oral TTM for Idiopathic Pulmonary Fibrosis (IPF)
Biopharmaceuticals FDA

HSMN NewsFeed - 8 May 2008
Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 28 Apr 2008
Regeneron and Bayer HealthCare Announce Encouraging 32-Week Follow-Up Results from a Phase 2 Study of VEGF Trap-Eye in Age-Related Macular Degeneration
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 17 Apr 2008
FDA Grants NeoVista's Request to Expand CABERNET Trial to 30 Sites in the U.S.
Devices Ophthalmology FDA

HSMN NewsFeed - 16 Apr 2008
OptiMedica Names Topcon Medical Japan as Exclusive Distribution Partner
Devices Ophthalmology Distribution

HSMN NewsFeed - 7 Apr 2008
Quark Pharmaceuticals, Inc. Closes $27 Million Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 1 Apr 2008
NeoVista Receives CE Mark Approval to Distribute Wet AMD Device in Europe
Devices Ophthalmology Regulatory

HSMN NewsFeed - 28 Mar 2008
NeoVista Presents One Year Data on Novel Wet AMD Therapy at Macula Society
Devices Ophthalmology

HSMN NewsFeed - 28 Mar 2008
Positive results from Visudyne(R) combination therapy study reported at Annual Macula Society Conference
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 25 Mar 2008
Micromet Establishes New Scientific Advisory Board for Its BiTE Antibody Technology with Leading Experts in the Fields of Oncology, Immunotherapy and Drug Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Mar 2008
DSMB Again Supports Continuation of the Phase III Clinical Trial of Medidur(TM) FA for the Treatment of DME
Biopharmaceuticals

HSMN NewsFeed - 18 Mar 2008
Alimera Sciences Closes $30 Million in Series C Financing, Increasing Stake in Medidur(TM) FA
Biopharmaceuticals Venture Capital Ophthalmology

HSMN NewsFeed - 10 Mar 2008
XOMA Appoints Mary L. Anderson as Vice President of Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Feb 2008
MacuSight Expands Management Team With Appointment of Dr. Joel Naor as Chief Medical Officer
Biopharmaceuticals Ophthalmology Personnel

HSMN NewsFeed - 1 Feb 2008
Taligen Therapeutics Secures Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 15 Jan 2008
American Academy of Ophthalmology Mourns Loss of Judah Folkman, MD, Pioneering Researcher
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Jan 2008
Cannasat Therapeutics Appoints Dr. Julia Levy to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Jan 2008
John Moore Appointed to STAAR Surgical Board Of Directors
Devices Ophthalmology Personnel

HSMN NewsFeed - 8 Jan 2008
Biogen Idec and PDL BioPharma License the Rights to Develop Volociximab in Ophthalmic Indications to Ophthotech
Biopharmaceuticals Ophthalmology Licensing

HSMN NewsFeed - 31 Dec 2007
OXiGENE Reports Positive Results in Phase 2 Study of ZYBRESTAT(TM) in Platinum-Resistant Ovarian Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 20 Dec 2007
EyeGate Pharma Appoints Remis Bistras as Vice President, Business Development
Devices Drug Delivery Personnel

HSMN NewsFeed - 14 Dec 2007
Micromet Announces Changes in Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Dec 2007
ThromboGenics Presents Results of the Vitreomacular Traction Trial (MIVI IIT) at the American Society of Retina Specialists Annual Meeting
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 29 Nov 2007
First European Patient Treated in CABERNET Trial With Novel Treatment for Wet AMD
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 19 Nov 2007
APT Pharmaceuticals Expands Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Nov 2007
OccuLogix Suspends RHEO(TM) System Clinical Development Program
Devices Ophthalmology

HSMN NewsFeed - 22 Oct 2007
AVANT Immunotherapeutics, Inc. and Celldex Therapeutics, Inc. Announce Merger Agreement
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 16 Oct 2007
Novadaq launches PINPOINT: Company's first minimally invasive imaging system
Devices Surgery

HSMN NewsFeed - 15 Oct 2007
Pipex Pharmaceuticals Appoints David A. Newsome, M.D. as Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Oct 2007
Optherion, Inc. Completes $37 Million Start Up Financing
Biopharmaceuticals Ophthalmology Venture Capital

HSMN NewsFeed - 8 Oct 2007
Steven Engle Appointed Chairman of XOMA
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Oct 2007
Novadaq Resumes Normal Business Operations by Securing ICG for SPY
Devices Surgery Radiology

HSMN NewsFeed - 2 Oct 2007
Othera Pharmaceuticals Appoints Dr. Frederick R. Rickles Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Sep 2007
Alcon Receives FDA Decision on RETAANE(R) Suspension for Wet AMD
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 12 Sep 2007
Micromet Appoints Mark Reisenauer as Senior Vice President and Chief Commercial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Sep 2007
Quark Pharmaceuticals Appoints New Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Aug 2007
Phase 3 Oncology Program for Aflibercept (VEGF Trap) Initiated by Regeneron and sanofi-aventis
Biopharmaceuticals Oncology

HSMN NewsFeed - 13 Aug 2007
Ophthotech Raises $36 Million; In-Licenses Two Compounds for Macular Degeneration
Biopharmaceuticals Ophthalmology Licensing

HSMN NewsFeed - 9 Aug 2007
Neurotech Names Richard Small Chief Financial Officer
Biopharmaceuticals Ophthalmology Personnel

HSMN NewsFeed - 7 Aug 2007
Lux Granted Fast Track Designation by FDA for LX211 for the Treatment of Uveitis
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 6 Aug 2007
XOMA Appoints Steven B. Engle President, Chief Executive Officer and Director
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Aug 2007
Regeneron and Bayer HealthCare Initiate Phase 3 Global Development Program For VEGF Trap-Eye In Wet Age-Related Macular Degeneration (AMD)
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 31 Jul 2007
EMEA Committee for Orphan Medicinal Products Recommends Orphan Medicinal Product Designation for Lux Biosciences' LX211 for the Treatment of Uveitis
Biopharmaceuticals Ophthalmology Regulatory

HSMN NewsFeed - 23 Jul 2007
Merrimack Pharmaceuticals Names William Slichenmyer, M.D. Senior Vice President and Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Jul 2007
Micromet Promotes Carsten Reinhardt to Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Jul 2007
TargeGen, Inc. Closes $40M Series 'D' Financing Round
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 10 Jul 2007
Pipex Pharmaceuticals Acquires Late-Stage Oral Candidate for Dry Age-Related Macular Degeneration (AMD)
Biopharmaceuticals Ophthalmology Licensing

HSMN NewsFeed - 18 Jun 2007
CoMentis Receives FDA Clearance to Begin Human Clinical Trials for Its Disease-Modifying Alzheimer's Therapy
Biopharmaceuticals Neurology

HSMN NewsFeed - 6 Jun 2007
CoMentis Announces Appointment of Martin Tolar, M.D., Ph.D., as Vice President of Strategic and Corporate Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 May 2007
Quest Group International, Inc. Raises $20 Million, Acquires Extensive New Generation Oncology Portfolio and Announces Three Lead Therapeutic Product Programs
Biopharmacetuicals Oncology Licensing

HSMN NewsFeed - 9 May 2007
Medennium, Inc.'s Photochromic IOL, Aurium Obtains CE Mark Approval
Devices Ophthalmology Regulatory

HSMN NewsFeed - 9 May 2007
VEGF Trap-Eye Phase 2 Wet AMD Results Reported at ARVO Annual Meeting
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 3 May 2007
Novadaq Completes Purchase of Xillix's Portfolio Of Fluorescence Endoscopy Patents
Devices Radiology Acquisitions

HSMN NewsFeed - 1 May 2007
QLT strengthens its expertise in ocular by adding David A. Saperstein M.D. as interim Chief Medical Officer and Paul L. Kaufman M.D. as Head of the Ocular Scientific Advisory Board
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Apr 2007
QLT announces that CHMP will recommend to the European Commission that occult indication be deleted from the Visudyne(R)label in European Union
Biopharmaceuticals Ophthalmology Regulatory

HSMN NewsFeed - 23 Apr 2007
Novadaq acquires portfolio of fluorescence endoscopy patents from Xillix
Devices Radiology Acquisitions

HSMN NewsFeed - 17 Apr 2007
Neurotech Initiates two Phase II/III Clinical Trials of NT-501 for the Treatment of Retinitis Pigmentosa
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 16 Apr 2007
Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic Drug to Treat Viral Eye Infection
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 12 Apr 2007
Synta Pharmaceuticals Corp. Strengthens Oncology Clinical and Commercial Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Apr 2007
XOMA Announces Clinical Trial Plans for XOMA 052 in Type 2 Diabetes
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 10 Apr 2007
CoMentis Initiates Phase II Clinical Trial for AMD Eye Drop Therapy
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 9 Apr 2007
Sirion Therapeutics Completes $45 Million Series B Financing
Biopharmaceuticals Ophthalmology Venture Capital

HSMN NewsFeed - 27 Mar 2007
Acuity Pharmaceuticals and Froptix Corporation Agree to Mergers with Public Shell; New Company to Develop and Market Drugs for Disorders of the Eye
Biopharmaceuticals Ophthalmology Mergers & Acquisitions

HSMN NewsFeed - 16 Mar 2007
Micromet and TRACON Pharmaceuticals Sign Exclusive Worldwide License Agreement to Develop and Commercialize D93, a Humanized Antibody for Cancer Treatment
Biopharmaceuticals Licensing

HSMN NewsFeed - 26 Feb 2007
XOMA Announces Planned Retirement of Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Feb 2007
Athenagen Announces Name Change to CoMentis
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 13 Feb 2007
Pfizer's Maraviroc to Receive Accelerated Regulatory Reviews in the U.S. and Europe
Biopharmaceuticals Regulatory HIV/AIDS

HSMN NewsFeed - 31 Jan 2007
Novadaq announces independent clinical results presented at STS
Devices Cardiology Radiology

HSMN NewsFeed - 29 Jan 2007
Novadaq imaging system receives FDA clearance for use during plastic reconstructive surgery
Devices Surgery

HSMN NewsFeed - 26 Jan 2007
Novadaq Establishes Direct US Sales Team
Devices Cardiology

HSMN NewsFeed - 19 Jan 2007
Bioptigen Receives FDA Clearance and Two Phase II SBIR Awards; Company to Exhibit at Major Technology Conference
Devices Ophthalmology

HSMN NewsFeed - 15 Jan 2007
Lux Biosciences Receives Orphan Drug Designation from the FDA for Two Ophthalmic Products
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 8 Jan 2007
Paradigm Medical Industries Announces Operations and Sales Management Reorganization
Devices Ophthalmology Personnel

HSMN NewsFeed - 8 Jan 2007
Nektar Appoints Howard W. Robin President and CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Jan 2007
Genaera Corporation Terminates EVIZON(TM) Clinical Program and Restructures
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 28 Dec 2006
Sirna Therapeutics Shareholders Approve Acquisition by Merck & Co.
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 21 Dec 2006
Isis Development Partner iCo Therapeutics Files IND for Antisense Drug to Treat Eye Disease
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 20 Dec 2006
Regeneron Reports Blocking New Angiogenesis Target May Offer Novel Approach to Slowing Tumor Growth
Biopharmaceuticals Oncology

HSMN NewsFeed - 14 Dec 2006
Merck & Co. and Sirna Therapeutics Announce Expiration of Hart-Scott-Rodino Waiting Period for the Proposed Acquisition of Sirna by Merck
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 14 Dec 2006
Ophthonix Completes Series D Financing at $35.1 Million
Devices Ophthalmology Venture Capital

HSMN NewsFeed - 16 Nov 2006
Neurotech(TM), Inc. Completes $35 Million Private Equity Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 11 Nov 2006
OptiMedica Launches Suite of Integrated Practice Solutions for the Pascal Photocoagulator
Devices Ophthalmology

HSMN NewsFeed - 9 Nov 2006
Genentech Announces Agreement to Acquire Tanox for $20 Per Share
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 8 Nov 2006
Carl Zeiss Meditec Announces Installation of 6000th Stratus OCT
Devices Ophthalmology

HSMN NewsFeed - 8 Nov 2006
OcuCure Therapeutics: Developing Novel Eye Drop Treatments for Wet and Dry Age-Related Macular Degeneration
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 7 Nov 2006
Cleveland Clinic Unveils 'Top 10' Medical Innovations for 2007
Devices Biopharmaceuticals Cardiology Oncology Neurology

HSMN NewsFeed - 6 Nov 2006
Novadaq announces CE Mark for OPTTX System
Devices Ophthalmology Regulatory

HSMN NewsFeed - 3 Nov 2006
Heidelberg Engineering Receives FDA Clearance for World's First Spectral Domain OCT and Laser Angiography Instrument
Devices Ophthalmology FDA

HSMN NewsFeed - 2 Nov 2006
MacuSight(TM) Appoints Brian C. Cunningham to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Nov 2006
Cellgate Commences Phase II Clinical Trial of Anticancer Compound CGC-11047 for Prostate Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 30 Oct 2006
Merck & Co., Inc. to Acquire Sirna Therapeutics, Inc.
Biopharmaceuticals Oncology Mergers & Acquisitions

HSMN NewsFeed - 30 Oct 2006
EyeGate Pharma Starts U.S. Operations in Waltham, MA
Biopharmaceuticals Ophthalmology Personnel

HSMN NewsFeed - 24 Oct 2006
Acuity Pharmaceuticals Appoints Denis O'Shaughnessy Senior Vice President of Clinical Development
Biopharmaceuticals Ophthalmology Personnel

HSMN NewsFeed - 23 Oct 2006
OccuLogix and Asahi Kasei Medical Sign Rheofilter'TM' SR Agreement
Devices Ophthalmology Distribution

HSMN NewsFeed - 20 Oct 2006
FDA Approves Prescription Zaditor(R) for Over-The-Counter Relief From Itchy Eyes
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 18 Oct 2006
Bayer HealthCare and Regeneron to Collaborate on VEGF Trap for the Treatment of Eye Diseases
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 16 Oct 2006
Genaera Presents New EVIZON(TM) Safety Data at the Angiogenesis Foundation 4th Annual International Conference
Biopharmacetuicals Ophthalmology

HSMN NewsFeed - 4 Oct 2006
New England Journal of Medicine Publishes Data From Lucentis Pivotal Phase III Studies in Wet Age-Related Macular Degeneration
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 28 Sep 2006
Athenagen Raises $50 Million in Series B Financing
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 26 Sep 2006
Pfizer Expands Research Commitment to Ophthalmology Through Licensing Agreement With Quark Biotech
Biopharmaceuticals Ophthalmology Licensing

HSMN NewsFeed - 25 Sep 2006
OptiMedica Announces Clinical Outcomes of 1,200 Patients Treated with PASCAL Method of Photocoagulation
Devices Ophthalmology

HSMN NewsFeed - 21 Sep 2006
OSI Pharmaceuticals Launches Study of Tarceva(R) as Adjuvant Treatment for Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 18 Sep 2006
Sirion Therapeutics, Inc. Combines With Tenby Pharma Inc.
Biopharmaceuticals Ophthalmology Mergers & Acquisitions

HSMN NewsFeed - 12 Sep 2006
OXiGENE to Focus Ophthalmology Strategy Toward Non-Invasive Administration of CA4P for Age-Related Macular Degeneration (AMD)
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 9 Sep 2006
OptiMedica Receives ISO Certification and CE Mark for the PASCAL(R) Photocoagulator
Devices Ophthalmology Regulatory

HSMN NewsFeed - 8 Sep 2006
Novadaq Announces European Distribution Contract with Kodak
Devices Radiology Distribution

HSMN NewsFeed - 7 Sep 2006
Metastatix Completes Series a Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 6 Sep 2006
XOMA's NEUPREX(R) Granted Orphan Status in Europe
Biopharmaceuticals Regulatory

HSMN NewsFeed - 6 Jul 2006
Alexion Pharmaceuticals Appoints David L. Hallal Vice President U.S. Commercial Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Jun 2006
FDA Approves LUCENTIS for the Treatment of Wet Age-Related Macular Degeneration
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 30 Jun 2006
OXiGENE'S Board of Directors Names Experienced Biotech Executive, Richard Chin, M.D., as President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Jun 2006
OSI Pharmaceuticals and Pfizer Announce Phase IV Macugen(R)(pegaptanib sodium injection) Maintenance Trial in Neovascular Age-Related Macular Degeneration (AMD)
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 26 Jun 2006
Lumenis Invests in Exclusive, Worldwide License for New Ophthalmic Technology
Devices Ophthalmology Licensing

HSMN NewsFeed - 2 Jun 2006
Preliminary Results from a Phase IIIb Study Showed Patients With Wet AMD Treated With Lucentis Quarterly Experienced a 16-Letter Benefit Over the Control Group at One Year
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 1 Jun 2006
Preliminary Topline Efficacy Results from Phase II Data Show Macugen(R) (pegaptanib sodium injection) Maintained or Improved Vision in over 90 Percent of Patients with Macular Edema Associated with Central Retinal Vein Occlusion (CRVO)
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 1 Jun 2006
Acuity Pharmaceuticals Reports Positive Initial Phase II Results for Bevasiranib (Cand5) in Wet AMD
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 18 May 2006
Baxter and Jerini Advance Program to Develop Non-Intravenous Hemophilia Therapy
Biopharmaceuticals

HSMN NewsFeed - 12 May 2006
Novadaq Announces Study Results Presented at the American Heart Association's Quality Conference
Devices Cardiology Radiology

HSMN NewsFeed - 11 May 2006
Boston Life Sciences, Inc. Solidifies Comprehensive Axon Regeneration Position with Children's Hospital Boston
Biopharmaceuticals Neurology Regenerative Medicine

HSMN NewsFeed - 10 May 2006
SurModics Licenses Ophthalmic Technology to Bausch & Lomb
Biopharmaceuticals Ophthalmology Licensing

HSMN NewsFeed - 9 May 2006
Novadaq receives FDA clearance for SPY labeling changes
Devices Surgery Cardiology FDA

HSMN NewsFeed - 8 May 2006
Athenagen Announces the Appointment of John Donovan as Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 May 2006
OSI Pharmaceuticals Summarizes Macugen(R) (pegaptanib sodium injection) Data Presented at Association for Research in Vision and Ophthalmology (ARVO) Meeting
Biopharmaceuticals Ophthalmology

Return to NewsFeed

Additional items found! 285

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 285 additional stories matching:
Macular Degeneration
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.